Research Ethics Board (REB)

At the Nova Scotia Health Authority, all research projects involving patients, staff, resources or data are reviewed and approved by the Research Ethics Board (REB) before the research begins. This requirement also applies to research involving human participants, human biological materials as well as human embryos, fetuses, fetal tissue, reproductive materials and stem cells. This applies to materials derived from living and deceased individuals.

The NSHA REB has the authority and resources to review research protocols that will be conducted within the Nova Scotia Health Authority. Board membership includes representatives from each zone who meet via video conference on a weekly basis. The NSHA REB is a paperless enterprise and the ROMEO database is the platform for on-line submissions to complete the research ethics review process.

The goals of the NSHA REB are to:

  • Meet the requirements of the Tri-Council Policy Statement Guidelines, ICH-GCP Guidelines, and Health Canada Division 5 Food and Drug Regulations which protect the safety and well being of research participants
  • Reduce review timelines and simultaneously maintain a high quality research ethics review
  • Increase the capacity throughout the province to conduct health research of all kinds
  • Attract and retain health professionals interested in research throughout the province
  • Create a competitive research environment that attracts research to Nova Scotia

Contact(s): REB Manager: Ken Jenkins, 902-473-8426, ken.jenkins@nshealth.ca

Administrative Coordinator: Nadine Ransome, 902-473-2126, nadine.ransome@nshealth.ca